SCHEMBL30401191

SCHEMBL30401191

CNc1nc(-c2cccc(C#N)c2)cc(-c2cn(Cc3cccc(COC)n3)nn2)n1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 10/20 0.39
▸ ADORA2B P29275 8/20 0.39
▸ ADORA1 P30542 2/20 0.39
▸ OXTR P30559 1/20 0.38
▸ AVPR1A P37288 1/20 0.38
▸ CYP19A1 P11511 1/20 0.38
▸ CTSS P25774 1/20 0.37
▸ CTSK P43235 1/20 0.37
▸ HDAC6 Q9UBN7 2/20 0.37
▸ HDAC2 Q92769 1/20 0.37
▸ HDAC8 Q9BY41 1/20 0.37
▸ PTGDR Q13258 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ ALOX12 P18054 1/20 0.36
▸ GPR55 Q9Y2T6 1/20 0.35
▸ MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20401313 1.00 ADORA2A (0.39) ADORA2AADORA2BADORA1OXTRAVPR1A
SCHEMBL20400724 0.91 ADORA2A (0.38) ADORA2AADORA2BADORA1OXTRAVPR1A
SCHEMBL30401216 0.91 ADORA2A (0.38) ADORA2AADORA2BADORA1OXTRAVPR1A
SCHEMBL20436629 0.90 ADORA2A (0.42) ADORA2AADORA2BADORA1CYP19A1CTSS
SCHEMBL20416870 0.90 PTGDR (0.38) ADORA2AADORA2BADORA1OXTRAVPR1A
SCHEMBL30401371 0.90 PTGDR (0.38) ADORA2AADORA2BADORA1OXTRAVPR1A
SCHEMBL30402211 0.89 ADORA2A (0.49) ADORA2AADORA2BADORA1
SCHEMBL20400534 0.89 ADORA2A (0.49) ADORA2AADORA2BADORA1
SCHEMBL20416742 0.89 CDC7 (0.43) ADORA2AADORA2BADORA1CYP19A1PTGDR
SCHEMBL30400427 0.89 ADORA2A (0.41) ADORA2AADORA2BADORA1OXTRAVPR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116768859-A Azolopyrimidines for the treatment of cancer related disorders 艾库斯生物科学有限公司 2023-09-19 — — CN disclosed
CN-110214012-B Azolopyrimidines for the treatment of cancer related disorders 艾库斯生物科学有限公司 2023-05-09 — — CN disclosed
Send feedback